Therapeutic potential for blockade of the CD40 ligand, gp39

[1] CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 669 - 674

[2] THE INDUCTION OF IMMUNOLOGICAL HYPORESPONSIVENESS BY PREOPERATIVE DONOR-SPECIFIC TRANSFUSIONS AND CYCLOSPORINE IN HUMAN CADAVERIC TRANSPLANTS - A PRELIMINARY TRIAL [J]. TRANSPLANTATION, 1992, 53 (02) : 423 - 427

[3] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J]. SCIENCE, 1993, 259 (5097) : 990 - 993

[4] ANDO DG, 1987, J IMMUNOL, V138, P3185

[5] ANTIN JH, 1992, BLOOD, V80, P2964

[6] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J]. CELL, 1993, 72 (02) : 291 - 300

[7] SUPPRESSED ANTIDONOR MLC RESPONSES IN RENAL-TRANSPLANT CANDIDATES CONDITIONED WITH DONOR-SPECIFIC TRANSFUSIONS THAT CARRY THE RECIPIENTS NONINHERITED MATERNAL HLA HAPLOTYPE [J]. TRANSPLANTATION, 1990, 49 (02) : 382 - 386

[8] BUHLMANN JE, 1995, IMMUNITY, V2, P645

[9] CD40-DEFICIENT MICE GENERATED BY RECOMBINATION-ACTIVATING GENE-2-DEFICIENT BLASTOCYST COMPLEMENTATION [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) : 12135 - 12139

[10] ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1263 - 1272

[1] CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40 [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 669 - 674

[2] THE INDUCTION OF IMMUNOLOGICAL HYPORESPONSIVENESS BY PREOPERATIVE DONOR-SPECIFIC TRANSFUSIONS AND CYCLOSPORINE IN HUMAN CADAVERIC TRANSPLANTS - A PRELIMINARY TRIAL [J]. TRANSPLANTATION, 1992, 53 (02) : 423 - 427

[3] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J]. SCIENCE, 1993, 259 (5097) : 990 - 993

[4] ANDO DG, 1987, J IMMUNOL, V138, P3185

[5] ANTIN JH, 1992, BLOOD, V80, P2964

[6] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J]. CELL, 1993, 72 (02) : 291 - 300

[7] SUPPRESSED ANTIDONOR MLC RESPONSES IN RENAL-TRANSPLANT CANDIDATES CONDITIONED WITH DONOR-SPECIFIC TRANSFUSIONS THAT CARRY THE RECIPIENTS NONINHERITED MATERNAL HLA HAPLOTYPE [J]. TRANSPLANTATION, 1990, 49 (02) : 382 - 386

[8] BUHLMANN JE, 1995, IMMUNITY, V2, P645

[9] CD40-DEFICIENT MICE GENERATED BY RECOMBINATION-ACTIVATING GENE-2-DEFICIENT BLASTOCYST COMPLEMENTATION [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) : 12135 - 12139

[10] ACTIVATION OF HUMAN DENDRITIC CELLS THROUGH CD40 CROSS-LINKING [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) : 1263 - 1272